Ching-Chiang Su

Title: The Innovative Contributions of Ching-Chiang Su

Introduction

Ching-Chiang Su, a prominent inventor based in Yardley, PA, has made significant strides in the field of pharmaceuticals with her innovative patented inventions. With a total of two patents to her name, she has focused on enhancing drug delivery and efficacy through her groundbreaking research.

Latest Patents

Her most recent patents include "Bioavailable Compositions of Amorphous Piperidinyl Compounds" and "Imidazole Prodrug LXR Modulators." The first patent relates to solid amorphous dispersions comprising a specific compound that exhibits surprising stability in suspension and solid state for prolonged periods, making it useful for tableting. The second patent discusses imidazole prodrugs and their pharmaceutically acceptable salts, which are designed to modulate the activity of liver X receptors (LXR), showcasing her commitment to advancing pharmaceutical science.

Career Highlights

Ching-Chiang Su is currently employed at Bristol-Myers Squibb Company, where she applies her expertise to further the company's mission in drug discovery and development. Her work holds the potential to significantly impact the pharmaceutical industry by improving patient outcomes through enhanced medication formulations.

Collaborations

Throughout her career, Su has collaborated with notable colleagues, including Michael J. Hageman and Rodney D. Vickery. These partnerships underscore the collaborative nature of innovation in scientific research, fostering an environment where inventive ideas can thrive.

Conclusion

Ching-Chiang Su is a remarkable inventor whose contributions to the pharmaceutical field illustrate the importance of innovation in healthcare. With her ongoing efforts at Bristol-Myers Squibb Company, she continues to pave the way for new advancements in drug formulations and therapeutic applications. Her work not only reflects her individual talent but also serves as an inspiration for future inventors in the industry.